BHCM
ZYME icon

Brevan Howard Capital Management’s Zymeworks ZYME Stock Holding History

Brevan Howard Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$678K Buy
+25,956
New +$659K 0.01% 1279
2026
Q1 		– Sell
-23,333
Closed -$614K – 2557
2025
Q4 		$614K Buy
23,333
+8,815
+61% +$192K 0.01% 1000
2025
Q3 		$248K Buy
14,518
+3,890
+37% +$55.7K ﹤0.01% 1659
2025
Q2 		$133K Buy
+10,628
New +$127K ﹤0.01% 1767

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Brevan Howard Capital Management's ZYME Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Zymeworks (ZYME) in Q2 2026: 25,956 shares worth $678K. The stake represents 0.01% of the portfolio and ranks #1279 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in ZYME as recently as Q4 2025.

Brevan Howard Capital Management first reported a position in ZYME in Q2 2025 and has held it in 4 quarters since. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Brevan Howard Capital Management held 25,956 shares of Zymeworks worth $678K as of Q2 2026.
  • Zymeworks was a new Brevan Howard Capital Management position in Q2 2026.
  • Zymeworks made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1279 holding.
  • Brevan Howard Capital Management first reported a position in Zymeworks in Q2 2025 and has held it in 4 quarters since.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.